The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
Authors
Keywords
-
Journal
BLOOD
Volume 135, Issue 21, Pages 1912-1915
Publisher
American Society of Hematology
Online
2020-04-17
DOI
10.1182/blood.2020006288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibiting Bruton’s tyrosine kinase rescues mice from lethal influenza-induced acute lung injury
- (2018) Jon M. Florence et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- BTKCys481Serdrives ibrutinib resistance via ERK1/2 and protects BTKwild-typeMYD88-mutated cells by a paracrine mechanism
- (2018) Jiaji G. Chen et al. BLOOD
- CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib
- (2017) Josephine M. Vos et al. HAEMATOLOGICA
- M1 Means Kill; M2 Means Heal
- (2017) Klaus Ley JOURNAL OF IMMUNOLOGY
- CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib
- (2017) Josephine M. Vos et al. HAEMATOLOGICA
- HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib
- (2016) G. Yang et al. BLOOD
- The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern To Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent Mechanism
- (2016) Yi Wang et al. mBio
- Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
- (2016) Stefania Fiorcari et al. Oncotarget
- Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib - Findings from an Investigator-Initiated Phase II Study
- (2015) C. U. Niemann et al. CLINICAL CANCER RESEARCH
- A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia
- (2013) G. Yang et al. BLOOD
- Alveolar Epithelial Cells Are Critical in Protection of the Respiratory Tract by Secretion of Factors Able To Modulate the Activity of Pulmonary Macrophages and Directly Control Bacterial Growth
- (2012) Olga D. Chuquimia et al. INFECTION AND IMMUNITY
- Innate Immune Responses to Bacterial Ligands in the Peripheral Human Lung – Role of Alveolar Epithelial TLR Expression and Signalling
- (2011) Andrew J. Thorley et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More